Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci

Clinical Infectious Diseases

Volumn 37, Issue 6, 2003, Pages 794-799

  Kim, Sung Han ^a   Park, Wan Bum ^a   Lee, Ki Deok ^a   Kang, Cheol In ^a   Kim, Hong Bin ^a   Oh, Myoung Don ^a,b   Kim, Eui Chong ^a,b   Choe, Kang Won ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CANCER; COHORT ANALYSIS; CONTROLLED STUDY; EMPIRICISM; ERADICATION THERAPY; FEMALE; HUMAN; LIVER CIRRHOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PENICILLIN RESISTANCE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; COHORT STUDIES; CROSS INFECTION; FEMALE; HUMANS; MALE; METHICILLIN; METHICILLIN RESISTANCE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE;

EID: 0141676166     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377540     Document Type: Article

References (18)

1. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999; 5:9-17.
2. Jensen AG, Wachmann CH, Espersen F, Scheihel J, Skinhoj P, Frimodt-Moller N. Treatment and outcome of Staphylococcus aureus bacteremia. Arch Intern Med 2002; 162:25-32.
3. Jensen AG. Importance of focus identification in the treatment of Staphylococcus aureus bacteremia. J Hosp Infect 2002; 52:29-36.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-9.
5. Sievert DM, Boulton ML, Stoltman G, et al. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:565-7.
6. NCCLS. Performance standards for antimicrobial disk susceptibility tests. Approved standard MZ-A5. Villanova, PA: NCCLS, 1993.
7. Soriano A, Martinez JA, Mensa J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000; 30:368-73.
8. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 158:182-9.
9. Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index: National Nosocomial Infections Surveillance System. Am J Med 1991; 91(Suppl 3B):152S-7S.
10. Durack DT, Lukes AS, Bright DK, et al. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96:200-9.
11. Iannini PB, Crossley K. Therapy of Staphylococcus aureus bacteremia associated with removable focus of infection. Ann Intern Med 1976; 84:558-60.
12. Chambers HF. Parenteral antibiotics for the treatment of bacteremia and other serious staphylococcal infections. In: Crossley KB, Archer GL, eds. The staphylococci in human disease. New York: Churchill Livingstone, 1997:583-601.
13. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug abusers. Antimicrob Agents Chemother 1990; 34:1227-31.
14. Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29:1171-7.
15. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002; 162:2229-35.
16. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19:32-7.
17. Roghmann MC. Predicting methicillin resistance and the effect of inadequate empirical therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000; 160:1001-4.
18. Lee MS, Kim DH, Kim H, et al. Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea. Int J Epidemiol 1998; 27:316-9.